about
The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeabilityImmunomodulatory functions of murine CR1/2.Detection of red blood cell surface antigens by probe-triggered cell collision and flow retardation in an autonomous microfluidic system.Synthesis of hepcidin derivatives in order to develop standards for immune adsorption method.Monovalent Fc receptor blockade by an anti-Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity.Bead arrays for antibody and complement profiling reveal joint contribution of antibody isotypes to C3 deposition.Generation of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases.Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model.Application of fluorescent monocytes for probing immune complexes on antigen microarrays.Ultrastructural localization of Hsp-72 examined with a new polyclonal antibody raised against the truncated variable domain of the heat shock protein.Regulation of B-cell activation by complement receptors CD21 and CD35.Exacerbation of collagen induced arthritis by Fcγ receptor targeted collagen peptide due to enhanced inflammatory chemokine and cytokine productionSerological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium.Non-CpG Oligonucleotides Exert Adjuvant Effects by Enhancing Cognate B Cell-T Cell Interactions, Leading to B Cell Activation, Differentiation, and Isotype Switching.The role of CR2 in autoimmunity.Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases.Altered expression of Fcgamma and complement receptors on B cells in systemic lupus erythematosus.Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.Life on a microarray: assessing live cell functions in a microarray format.Label-free detection of immune complexes with myeloid cells.Built-in adjuvanticity of genetically and protein-engineered chimeric molecules for targeting of influenza A peptide epitopes.Transgenic expression of bovine neonatal Fc receptor in mice boosts immune response and improves hybridoma production efficiency without any sign of autoimmunity.B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.Mucosal type mast cells express complement receptor type 2 (CD21).Modeling the presentation of C3d-coated antigen by B lymphocytes: enhancement by CR1/2-BCR co-ligation is selective for the co-ligating antigen.CD16/32-specific biotinylated 2.4G2 single-chain Fv complexed with avidin-FITC enhances FITC-specific humoral immune response in vivo in a CD16-dependent manner.Coadministration of antigen-conjugated and free CpG: effects of in vitro and in vivo interactions in a murine model.Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production.A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes.Recognition of new citrulline-containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients.On-chip complement activation adds an extra dimension to antigen microarrays.Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays.Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies.Characterization of factors influencing on-chip complement activation to optimize parallel measurement of antibody and complement proteins on antigen microarrays.[Hypothetical connection between diabetes mellitus and free radical reactions in arteriosclerosis]IntroductionAntigen microarrays: descriptive chemistry or functional immunomics?Modulation of immune response by combined targeting of complement receptors and low-affinity Fcγ receptorsProgression of lupus-like disease drives the appearance of complement-activating IgG antibodies in MRL/lpr miceAn antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes
P50
Q28649846-CA269D24-E83A-43D8-83BE-597556B6574CQ30327017-EBCAC2BA-C689-437C-8C90-3BB3D9387A69Q30850641-10E5C4B8-B365-4F61-944E-C7240D1F6762Q33405107-87131947-4DAB-4EF1-8A60-85BAF80E591DQ33427026-02BBAF04-FF32-40F2-A9F0-EFD401580FBAQ33568195-6363F199-C1B6-4744-A008-0DF7E7B2681AQ33568195-C099AA39-6139-4E50-8E6C-DC3E25411EF4Q33586280-E8548F28-A6A6-4A93-AE7E-E2DEDBBC4B3CQ33631222-E24373BE-659E-4B67-8E9A-EFEF7C4B5CE5Q34988379-3AF19166-AEC8-4FF9-97B6-D8CF3CFA8B26Q35085353-524B21AD-3B55-4A02-B397-13304381A6D2Q35181488-B726F6AC-A012-4F97-89CF-7C0B5E194853Q35905956-33C6976C-3D14-4E83-9450-7BA6417DE1ABQ35948092-AAF8E31C-FEF1-476D-B164-A9D81B7BCDF2Q36034711-BFC9A976-4FE3-49C2-B95E-79BA3E7CD143Q36572973-135F65C6-A157-4AB5-835C-9931C0BD70E4Q36810295-760653CA-65E1-47CF-B79F-6E8AEA5DC3C7Q36951031-1B69F972-0D2E-4811-A508-E0FDD219C9EBQ37533028-867BEA00-CD33-4CF9-9A51-38C6E65D2630Q37990731-34B8B61A-98E8-42AA-BE66-CB01488039C5Q38787980-473808D6-6A1C-4E8D-B484-077E9903195BQ39025132-4CB339CB-8D98-44C5-B794-44A732D36EC0Q39588593-E2642CD4-398A-40B7-BF3F-2650F7D45E97Q40025657-C8BD2481-5BCD-4220-8B9B-4570D57F74F3Q40732437-382864D6-AE22-4E65-B36D-0FFF09E6AD03Q40748022-D352C1EF-46BC-4232-B58A-5E933DAC1279Q43232758-5926E852-0530-4B0C-B5A6-218830B570A0Q43432241-65CD1DCC-EA5A-4836-B2AB-151BA6D56DC6Q44705232-D5A4F477-83E5-41E1-85A1-A55268385046Q44884270-C69DB4F5-AF04-4F50-AF9F-D41385CE9D00Q46340323-1594330A-CDF6-4859-9EA2-2573DF32C226Q47179656-D7F98002-0E31-4973-A8BA-C6AD887E0548Q47714091-19DB053A-D7AB-4616-8607-1B52D19A512CQ47946798-9D6C389E-98DA-47FC-9B16-5267538F69E5Q51545290-E50128C1-C0A4-4A87-8B0A-4CDBDDEEBB8BQ54197540-644E1F5E-E70F-465D-BC96-67424C3C564DQ60861345-D80755CB-7304-4528-8D80-71EDAFE431DFQ60861409-CC6CA1A0-20F9-4675-8704-54D74332EA77Q60861434-8A4C11BA-A042-4F88-9D13-7525C0DBB6B4Q60861438-0328672B-BD23-4458-AABD-2E30154F99BA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
József Prechl
@ast
József Prechl
@en
József Prechl
@es
József Prechl
@nl
type
label
József Prechl
@ast
József Prechl
@en
József Prechl
@es
József Prechl
@nl
prefLabel
József Prechl
@ast
József Prechl
@en
József Prechl
@es
József Prechl
@nl
P106
P31
P496
0000-0003-3859-4353